Albert David Limited (ALBERTDAVD.NS)
INR 1355.05
(-0.19%)
INR 1355.05
(-0.19%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3.62 Billion INR | 6.12% |
| 2022 | 3.41 Billion INR | 9.33% |
| 2021 | 3.12 Billion INR | 26.84% |
| 2020 | 2.46 Billion INR | -22.65% |
| 2019 | 3.18 Billion INR | 1.83% |
| 2018 | 3.12 Billion INR | 8.73% |
| 2017 | 2.87 Billion INR | -5.18% |
| 2016 | 3.03 Billion INR | -5.46% |
| 2015 | 3.2 Billion INR | 0.11% |
| 2014 | 3.2 Billion INR | 10.58% |
| 2013 | 2.89 Billion INR | 10.32% |
| 2012 | 2.62 Billion INR | 13.67% |
| 2011 | 2.31 Billion INR | 5.78% |
| 2010 | 2.18 Billion INR | 7.66% |
| 2009 | 2.02 Billion INR | 10.36% |
| 2008 | 1.83 Billion INR | 16.31% |
| 2007 | 1.58 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 893.56 Million INR | 0.34% |
| 2023 Q3 | 882.81 Million INR | -5.25% |
| 2023 Q4 | 890.57 Million INR | 0.88% |
| 2023 Q1 | 919.47 Million INR | 12.93% |
| 2023 Q2 | 931.76 Million INR | 1.34% |
| 2023 FY | 3.62 Billion INR | 6.12% |
| 2022 Q1 | 931.97 Million INR | 27.17% |
| 2022 FY | 3.41 Billion INR | 9.33% |
| 2022 Q2 | 923.77 Million INR | -0.88% |
| 2022 Q4 | 814.2 Million INR | 9.19% |
| 2022 Q3 | 745.69 Million INR | -19.28% |
| 2021 Q2 | 863.38 Million INR | 6.46% |
| 2021 Q4 | 732.88 Million INR | 2.22% |
| 2021 FY | 3.12 Billion INR | 26.84% |
| 2021 Q1 | 811 Million INR | 45.86% |
| 2021 Q3 | 716.98 Million INR | -16.96% |
| 2020 Q3 | 652.92 Million INR | -8.92% |
| 2020 Q2 | 716.87 Million INR | 33.42% |
| 2020 Q1 | 537.31 Million INR | -6.78% |
| 2020 FY | 2.46 Billion INR | -22.65% |
| 2020 Q4 | 556.02 Million INR | -14.84% |
| 2019 Q4 | 576.4 Million INR | -27.55% |
| 2019 FY | 3.18 Billion INR | 1.83% |
| 2019 Q1 | 916.22 Million INR | 44.29% |
| 2019 Q2 | 896.11 Million INR | -2.19% |
| 2019 Q3 | 795.57 Million INR | -11.22% |
| 2018 Q2 | 778.46 Million INR | -17.54% |
| 2018 Q4 | 635 Million INR | -17.48% |
| 2018 FY | 3.12 Billion INR | 8.73% |
| 2018 Q1 | 944.1 Million INR | 36.55% |
| 2018 Q3 | 769.47 Million INR | -1.16% |
| 2017 Q2 | 924.52 Million INR | 72.92% |
| 2017 FY | 2.87 Billion INR | -5.18% |
| 2017 Q4 | 691.4 Million INR | -7.37% |
| 2017 Q3 | 746.41 Million INR | -19.26% |
| 2017 Q1 | 534.65 Million INR | -25.25% |
| 2016 Q3 | 609.53 Million INR | -35.78% |
| 2016 FY | 3.03 Billion INR | -5.46% |
| 2016 Q1 | 802.05 Million INR | 15.81% |
| 2016 Q2 | 949.09 Million INR | 18.33% |
| 2016 Q4 | 715.23 Million INR | 17.34% |
| 2015 Q3 | 731.19 Million INR | -23.02% |
| 2015 FY | 3.2 Billion INR | 0.11% |
| 2015 Q1 | 849.39 Million INR | 26.55% |
| 2015 Q2 | 949.81 Million INR | 11.82% |
| 2015 Q4 | 692.57 Million INR | -5.28% |
| 2014 Q3 | 765.7 Million INR | -18.97% |
| 2014 Q4 | 671.21 Million INR | -12.34% |
| 2014 Q2 | 944.93 Million INR | 14.82% |
| 2014 Q1 | 822.95 Million INR | 11.54% |
| 2014 FY | 3.2 Billion INR | 10.58% |
| 2013 Q3 | 640.3 Million INR | -21.43% |
| 2013 Q4 | 737.8 Million INR | 15.23% |
| 2013 Q1 | 705.1 Million INR | 11.17% |
| 2013 FY | 2.89 Billion INR | 10.32% |
| 2013 Q2 | 814.93 Million INR | 15.58% |
| 2012 Q1 | 662.44 Million INR | 11.03% |
| 2012 FY | 2.62 Billion INR | 13.67% |
| 2012 Q4 | 634.25 Million INR | 17.03% |
| 2012 Q3 | 541.97 Million INR | -31.26% |
| 2012 Q2 | 788.46 Million INR | 19.02% |
| 2011 Q4 | 596.63 Million INR | 23.88% |
| 2011 FY | 2.31 Billion INR | 5.78% |
| 2011 Q2 | 637.32 Million INR | 0.0% |
| 2011 Q3 | 481.6 Million INR | -24.43% |
| 2010 FY | 2.18 Billion INR | 7.66% |
| 2009 FY | 2.02 Billion INR | 10.36% |
| 2008 FY | 1.83 Billion INR | 16.31% |
| 2007 FY | 1.58 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Sigachi Industries Limited | 3.98 Billion INR | 9.147% |
| Ind-Swift Limited | 5.02 Billion INR | 27.864% |
| Bajaj HealthCare Limited | 4.73 Billion INR | 23.437% |
| Sakar Healthcare Limited | 1.54 Billion INR | -135.109% |
| Aurobindo Pharma Limited | 290.01 Billion INR | 98.75% |
| Innova Captab Limited | 10.81 Billion INR | 66.479% |
| Divi's Laboratories Limited | 78.45 Billion INR | 95.38% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | 72.022% |
| Morepen Laboratories Limited | 17.01 Billion INR | 78.703% |
| Mankind Pharma Limited | 103.34 Billion INR | 96.493% |
| Sequent Scientific Limited | 13.69 Billion INR | 73.538% |
| Wanbury Limited | 5.75 Billion INR | 37.034% |
| Laurus Labs Limited | 50.01 Billion INR | 92.753% |
| Nectar Lifesciences Limited | 16.84 Billion INR | 78.483% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | 84.125% |
| Alembic Limited | 1.57 Billion INR | -130.156% |
| Hikal Limited | 17.84 Billion INR | 79.689% |
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | 94.07% |
| Neuland Laboratories Limited | 15.58 Billion INR | 76.744% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.47 Billion INR | 89.487% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | 96.932% |
| IOL Chemicals and Pharmaceuticals Limited | 21.32 Billion INR | 83.005% |
| Themis Medicare Limited | 3.81 Billion INR | 5.055% |
| RPG Life Sciences Limited | 5.82 Billion INR | 37.727% |
| Zydus Lifesciences Limited | 190.21 Billion INR | 98.094% |
| Lupin Limited | 196.56 Billion INR | 98.156% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | 13.952% |
| Wockhardt Limited | 27.89 Billion INR | 87.004% |
| Vaishali Pharma Limited | 862.79 Million INR | -320.101% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | 80.035% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -73.674% |
| Jubilant Pharmova Limited | 67.02 Billion INR | 94.592% |
| FDC Limited | 19.42 Billion INR | 81.345% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 98.702% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -134.797% |
| Eris Lifesciences Limited | 20.09 Billion INR | 81.959% |
| Venus Remedies Limited | 5.91 Billion INR | 38.716% |
| ZIM Laboratories Limited | 3.67 Billion INR | 1.376% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | 52.942% |
| Par Drugs and Chemicals Limited | 956.4 Million INR | -278.984% |
| Caplin Point Laboratories Limited | 16.76 Billion INR | 78.383% |
| Shilpa Medicare Limited | 11.53 Billion INR | 68.567% |
| Ajanta Pharma Limited | 42.08 Billion INR | 91.388% |
| Hester Biosciences Limited | 3.04 Billion INR | -19.017% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | 65.524% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | 70.731% |
| Gufic Biosciences Limited | 8.06 Billion INR | 55.067% |
| Windlas Biotech Limited | 6.3 Billion INR | 42.554% |
| Procter & Gamble Health Limited | 11.51 Billion INR | 68.516% |
| Aarey Drugs & Pharmaceuticals Limited | 3.95 Billion INR | 8.381% |
| Mangalam Drugs & Organics Limited | 3.67 Billion INR | 1.332% |
| Granules India Limited | 45.06 Billion INR | 91.957% |
| Aarti Drugs Limited | 25.28 Billion INR | 85.665% |
| Bal Pharma Limited | 3.39 Billion INR | -6.852% |
| Alkem Laboratories Limited | 126.67 Billion INR | 97.139% |
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 99.253% |
| Lincoln Pharmaceuticals Limited | 5.8 Billion INR | 37.566% |
| Medicamen Biotech Limited | 1.79 Billion INR | -102.147% |
| Unichem Laboratories Limited | 16.57 Billion INR | 78.131% |
| Bafna Pharmaceuticals Limited | 1.52 Billion INR | -137.733% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -805.355% |
| Valiant Laboratories Limited | 1.82 Billion INR | -99.092% |
| Orchid Pharma Limited | 8.19 Billion INR | 55.763% |
| Medico Remedies Limited | 1.44 Billion INR | -150.11% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | 71.703% |
| Ipca Laboratories Limited | 77.05 Billion INR | 95.296% |
| Brooks Laboratories Limited | 794.86 Million INR | -356.006% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -39.815% |
| Piramal Enterprises Limited | 60.33 Billion INR | 93.993% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | 96.582% |
| NATCO Pharma Limited | 40.02 Billion INR | 90.943% |
| Suven Life Sciences Limited | 116.92 Million INR | -2999.844% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -618.863% |
| Strides Pharma Science Limited | 40.51 Billion INR | 91.053% |
| Indoco Remedies Limited | 18.17 Billion INR | 80.055% |
| Alpa Laboratories Limited | 1.08 Billion INR | -233.332% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -247.402% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -379.794% |